Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Understanding what to expect in financial planning for 2025 is crucial for adapting your strategies. Stay informed and ready.
22,201 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
If you crave a reliable, growing cash flow from your investments, energy stocks can be a smart piece of the puzzle. T...
In a surprise move, President Trump names Senator Markwayne Mullin to head the Department of Homeland Security. Mulli...
AI is reshaping hiring in three AI-driven domains, even as revenue growth decouples from headcount. The shift signals...
A once-dismissed Google-backed AI fund has closed a $220 million fifth fund, illustrating how the seeds of AI investi...
Markets can stay calm even when prices rise, but two hidden forces often lurk beneath the surface. This guide identif...
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
A16z publishes a sharp rebuttal to fears about a sweeping AI job apocalypse, framing the debate through the lens of t...
A Houston geothermal startup storms Wall Street, delivering the clean energy sector’s largest IPO to date with a $10B...
BitGo and Galaxy Digital continue their in-court battle over a failed $1.2 billion merger, with BitGo seeking damages...
Curious about building decades of passive income through resilient dividends? This guide breaks down three energy sto...
A 53-year-old caregiver was denied Social Security Disability Insurance after a denial tied to the recent-work test, ...